Fengmin Shao

Azvudine is a thymus-homing anti-SARS-CoV-2 drug effective in treating COVID-19 patients

Jinlan Zhang, Yuhuan Li, Lulu Wang et al. · Signal Transduction and Targeted Therapy · 2021 · 197 citations · Full text

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

PK Judge, Natalie Staplin, KJ Mayne et al. · The Lancet Diabetes & Endocrinology · 2023 · 88 citations · Full text

Hsa_circ_0035483 sponges hsa-miR-335 to promote the gemcitabine-resistance of human renal cancer cells by autophagy regulation

Lei Yan, Guang‐Hui Liu, Huixia Cao et al. · Biochemical and Biophysical Research Communications · 2019 · 83 citations · Full text

LncRNA MILIP links YBX1 to translational activation of Snai1 and promotes metastasis in clear cell renal cell carcinoma

Yanliang Wang, Yuchen Feng, Yujin Gan et al. · Journal of Experimental & Clinical Cancer Research · 2022 · 68 citations · Full text

Application and Preliminary Outcomes of Remote Diagnosis and Treatment During the COVID-19 Outbreak: Retrospective Cohort Study

Luwen Liu, Jianqin Gu, Fengmin Shao et al. · JMIR mhealth and uhealth · 2020 · 67 citations · Full text